Thomson Reuters Injects Drug Data into Eikon

The app allows researchers to identify drug pipelines and companies' exposure to particular areas.

tr-healthcare-intelligence-eikon

Dubbed Healthcare Intelligence, the app uses content from Thomson Reuters' Cortellis life sciences data platform to provide a "one-stop location" for existing and in-development pharmaceuticals, and was developed in response to client demand for access to consolidated information from different sources to make it easier to identify a company's existing presence and R&D pipeline for particular drugs or diseases.

The vendor's Cortellis platform covers more than 61,000 drugs under development and

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Waters Wrap: The tough climb for startups

Anthony speaks with two seasoned technologists to better understand why startups have such a tough time getting banks and asset managers to sign on the dotted line.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here